Lucid Diagnostics Inc - LUCD Net earnings per share for the last four quarters

Official company branding of Lucid Diagnostics, Inc. (LUCD)

Lucid Diagnostics Inc. (LUCD) is actively expanding the distribution of its diagnostic systems, focusing on securing agreements with insurance companies. The GURU.Markets quotes provided below for the EPS (TTM) metric are 54.10. The business attracts leading scientists through the prestige of its developments in combating esophageal oncology. Economic efficiency is achieved by centralizing laboratory processes, which reduces costs as the number of screenings increases.

LUCD luciddx.com: Earnings per share for the last twelve months in the range 02/11/2024 - 11/15/2026

luciddx.com - analytical breakdowns and key metrics (LUCD)

- market price and analyst price targets:
Market Chart Lucid Diagnostics|LUCD - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization Lucid Diagnostics, Inc|LUCD - Total Company Value
- book value of equity indicators:
Net Assets per Share Lucid Diagnostics|LUCD - Company Book Value|Market Value to Book Value Ratio luciddx.com|LUCD - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Lucid Diagnostics Inc.|LUCD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Lucid Diagnostics Inc.|LUCD - Company Aggregate Debts|Debts to Net Assets Lucid Diagnostics Inc|LUCD - Company Long-Term Debts|Company Short-Term Indebtedness Lucid Diagnostics|Intermediate Coverage Ratio luciddx.com
- business earnings and investment ratios data:
LUCD - Net Profit|Net Profit Forecast Lucid Diagnostics Inc.|LUCD - P/E Multiple|Market Cap to Projected Earnings Lucid Diagnostics Inc|LUCD - PEG Multiple|EV/EBITDA Multiple Lucid Diagnostics Inc|LUCD - Operating profit EBITDA|Net earnings per share for the trailing year Lucid Diagnostics|LUCD - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months luciddx.com|LUCD - Earnings per share growth in current year|Expected net earnings per share growth next year Lucid Diagnostics Inc.
- revenue and sales details:
LUCD - Company Revenue|Company Future Sales Lucid Diagnostics Inc|LUCD - Market Cap to Revenue|Price to Expected Revenue Ratio Lucid Diagnostics Inc
Fundamental company valuation:LUCD (Lucid Diagnostics)
Mass-produced product of Lucid Diagnostics Inc.

Lucid Diagnostics Inc. (LUCD) leverages efficient medical logistics to accelerate cancer diagnostics, directly impacting operating revenue. These achievements translate into the calculated difference in net income per share over the last twelve months compared to the previous year. This metric measures the real dynamics of return on equity, excluding subjective forecasts. Analyzing the rolling change in earnings per share YoY allows for an objective assessment of the issuer's financial stability.

Competitor analysis for Lucid Diagnostics Inc.

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) Anbio Biotechnology Ltd (NNNN)|Sotera Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) QuidelOrtho Corp QDEL|OPK - Earnings per share for the last twelve months|Earnings per share for the trailing year CDNA (caredx.com)|MRVI: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Fulgent Genetics FLGT|LAB (Standard BioTools Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Cytek Biosciences, Inc.|Earnings per share for the last twelve months OraSure Technologies (OSUR)|XGN (Exagen) - Earnings per share for the trailing year|Earnings per share for the last twelve months MDxHealth MDXH|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)